Multidisciplinary care in pediatric severe asthma: A comparative outcomes analysis

Adam S. Price MD , Akilah A. Jefferson-Shah MD , Robert D. Pesek MD , Erhan Ararat MD , Safia F. Nawaz MD , Matthew Pertzborn MD , Kim Cobb RT , Haley Long RT , Monica Y. Miller LMSW , Brandi N. Whitaker PhD , Stacie M. Jones MD , Scott Stewart MS , Daniel Liu MD , Tamara T. Perry MD
{"title":"Multidisciplinary care in pediatric severe asthma: A comparative outcomes analysis","authors":"Adam S. Price MD ,&nbsp;Akilah A. Jefferson-Shah MD ,&nbsp;Robert D. Pesek MD ,&nbsp;Erhan Ararat MD ,&nbsp;Safia F. Nawaz MD ,&nbsp;Matthew Pertzborn MD ,&nbsp;Kim Cobb RT ,&nbsp;Haley Long RT ,&nbsp;Monica Y. Miller LMSW ,&nbsp;Brandi N. Whitaker PhD ,&nbsp;Stacie M. Jones MD ,&nbsp;Scott Stewart MS ,&nbsp;Daniel Liu MD ,&nbsp;Tamara T. Perry MD","doi":"10.1016/j.jacig.2025.100417","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>There are limited data comparing the effectiveness of multidisciplinary severe asthma clinics (SACs) with that of conventional single-discipline clinics (SDCs) for pediatric severe asthma.</div></div><div><h3>Objective</h3><div>Our aim was to compare asthma outcomes between SACs and SDCs clinics and examine longitudinal health outcomes for patients with severe asthma who were followed in SACs.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study comparing pediatric asthma outcomes among patients with severe asthma between 2018 and 2022 who were treated at the multidisciplinary Arkansas Children's SAC with those of patients with severe asthma treated at SDCs. The primary outcome was acute health care utilization, including hospitalizations and emergency department visits. Secondary outcomes included systemic corticosteroid prescriptions and controller medications. For SAC enrollees, longitudinal outcomes including health care utilization, symptom control, and spirometry were evaluated 12 months before and after enrollment. Data sources included the electronic health record and SAC patient registry.</div></div><div><h3>Results</h3><div>The study population included 280 patients with severe asthma, aged 5 to 18 years, from the SAC (n = 56) and SDCs (n = 224). The SAC patients were more likely to be Black (79% vs 52% [<em>P</em> = .0002]), be non-Hispanic (100% vs 88% [<em>P</em> = .01]), have had at least 1 hospitalization (21% vs 10% [<em>P</em> = .04]), and have received at least 2 prescriptions for a systemic corticosteroid (34% vs 17% [<em>P</em> = .01]). Longitudinal outcomes among patients for the 12 months before SAC enrollment versus 12 months after SAC enrollment demonstrated significant reductions in acute exacerbations (from 35 to 8 [<em>P</em> &lt; .001]), hospitalizations (from 21 to 1 [<em>P</em> &lt; .001]), and intensive care unit admissions (from 8 to 1 [<em>P</em> = .02]).</div></div><div><h3>Conclusions</h3><div>The study highlights significant morbidity among predominately Black pediatric patients with severe asthma, particularly those followed in a SAC versus in SDCs at a tertiary care referral center. The findings demonstrate the value of targeted multidisciplinary approaches to reduce asthma utilization and improve outcomes among high-risk patients.</div></div>","PeriodicalId":75041,"journal":{"name":"The journal of allergy and clinical immunology. Global","volume":"4 2","pages":"Article 100417"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The journal of allergy and clinical immunology. Global","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772829325000189","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

There are limited data comparing the effectiveness of multidisciplinary severe asthma clinics (SACs) with that of conventional single-discipline clinics (SDCs) for pediatric severe asthma.

Objective

Our aim was to compare asthma outcomes between SACs and SDCs clinics and examine longitudinal health outcomes for patients with severe asthma who were followed in SACs.

Methods

We conducted a retrospective cohort study comparing pediatric asthma outcomes among patients with severe asthma between 2018 and 2022 who were treated at the multidisciplinary Arkansas Children's SAC with those of patients with severe asthma treated at SDCs. The primary outcome was acute health care utilization, including hospitalizations and emergency department visits. Secondary outcomes included systemic corticosteroid prescriptions and controller medications. For SAC enrollees, longitudinal outcomes including health care utilization, symptom control, and spirometry were evaluated 12 months before and after enrollment. Data sources included the electronic health record and SAC patient registry.

Results

The study population included 280 patients with severe asthma, aged 5 to 18 years, from the SAC (n = 56) and SDCs (n = 224). The SAC patients were more likely to be Black (79% vs 52% [P = .0002]), be non-Hispanic (100% vs 88% [P = .01]), have had at least 1 hospitalization (21% vs 10% [P = .04]), and have received at least 2 prescriptions for a systemic corticosteroid (34% vs 17% [P = .01]). Longitudinal outcomes among patients for the 12 months before SAC enrollment versus 12 months after SAC enrollment demonstrated significant reductions in acute exacerbations (from 35 to 8 [P < .001]), hospitalizations (from 21 to 1 [P < .001]), and intensive care unit admissions (from 8 to 1 [P = .02]).

Conclusions

The study highlights significant morbidity among predominately Black pediatric patients with severe asthma, particularly those followed in a SAC versus in SDCs at a tertiary care referral center. The findings demonstrate the value of targeted multidisciplinary approaches to reduce asthma utilization and improve outcomes among high-risk patients.
儿童重症哮喘的多学科治疗:比较结果分析
多学科重症哮喘诊所(SACs)与传统单学科诊所(sdc)治疗小儿重症哮喘的有效性比较数据有限。我们的目的是比较SACs和SDCs诊所之间的哮喘结局,并检查SACs随访的严重哮喘患者的纵向健康结局。方法:我们进行了一项回顾性队列研究,比较2018年至2022年期间在阿肯色儿童多学科SAC治疗的严重哮喘患者与在sdc治疗的严重哮喘患者的儿童哮喘结局。主要结局是急性医疗保健的利用,包括住院和急诊就诊。次要结果包括全身性皮质类固醇处方和对照药物。对于SAC入组者,在入组前和入组后12个月对包括医疗保健利用、症状控制和肺活量测定在内的纵向结果进行评估。数据来源包括电子健康记录和SAC患者登记。结果研究人群包括280例5 - 18岁的重度哮喘患者,分别来自SAC (n = 56)和sdc (n = 224)。SAC患者更可能是黑人(79%对52% [P = .0002])、非西班牙裔(100%对88% [P = .01])、至少住院过一次(21%对10% [P = .04])、至少接受过2次全身性皮质类固醇处方(34%对17% [P = .01])。患者在SAC入组前12个月与SAC入组后12个月的纵向结果显示,急性加重发生率显著降低(从35例降至8例)[P <;.001]),住院率(从21至1例[P <;.001])和重症监护病房入院率(从8到1 [P = .02])。结论:该研究强调了黑人儿童重症哮喘患者的显著发病率,特别是在SAC和sdc的三级保健转诊中心。研究结果表明,有针对性的多学科方法在减少哮喘利用和改善高危患者预后方面的价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
The journal of allergy and clinical immunology. Global
The journal of allergy and clinical immunology. Global Immunology, Allergology and Rheumatology
CiteScore
0.70
自引率
0.00%
发文量
0
审稿时长
92 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信